Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
July 14, 2009updated 02 Dec 2021 5:26am

Japan’s Hisamitsu to Buy Noven Pharmaceuticals

Japan's Hisamitsu, a pharmaceuticals and health goods manufacturer, has announced the purchase of US Miami-based Noven Pharmaceuticals for $430m. The venture to make Noven a wholly owned subsidiary is part of Hisamitsu's goal of growing its presence in the US. Hisamitsu will pay

By cms admin

Japan’s Hisamitsu a pharmaceuticals and health goods manufacturer, has announced the purchase of US Miami-based Noven Pharmaceuticals for $430m.

The venture to make Noven a wholly owned subsidiary is part of Hisamitsu’s goal of growing its presence in the US.

Hisamitsu will pay $16.50 for each Noven share, representing a 38% premium on Noven’s 50-day moving average share price of $11.95.

The deal would make Noven a wholly owned subsidiary when completed in August, raising Hisamitsu’s stake in the firm up from its current 4.98% stake.

Noven, which specialises in hormone therapies for women as well as drug delivery patches, will name Jeffrey Eisenberg as president and chief executive and will remain a standalone business.

Content from our partners
Extractables and leachables analysis in pharmaceutical quality control
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU